1. Home
  2. TRIP vs DRTS Comparison

TRIP vs DRTS Comparison

Compare TRIP & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TripAdvisor Inc.

TRIP

TripAdvisor Inc.

N/A

Current Price

$14.55

Market Cap

1.2B

Sector

Technology

ML Signal

N/A

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

N/A

Current Price

$11.85

Market Cap

978.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TRIP
DRTS
Founded
2000
2015
Country
United States
Israel
Employees
N/A
121
Industry
Computer Software: Programming Data Processing
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
978.2M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
TRIP
DRTS
Price
$14.55
$11.85
Analyst Decision
Hold
Strong Buy
Analyst Count
13
3
Target Price
$14.40
$8.67
AVG Volume (30 Days)
2.6M
803.0K
Earning Date
05-07-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
675.00
N/A
EPS
N/A
N/A
Revenue
$1,556,000,000.00
N/A
Revenue This Year
$3.33
N/A
Revenue Next Year
$5.12
$699.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.01
$2.87
52 Week High
$20.16
$14.11

Technical Indicators

Market Signals
Indicator
TRIP
DRTS
Relative Strength Index (RSI) 60.88 43.80
Support Level $13.04 $6.59
Resistance Level $15.33 $11.48
Average True Range (ATR) 0.57 0.91
MACD -0.08 -0.23
Stochastic Oscillator 75.41 1.19

Price Performance

Historical Comparison
TRIP
DRTS

About TRIP TripAdvisor Inc.

Tripadvisor is the world's leading travel metasearch company. Its platform offers 1 billion reviews and information on several million accommodations, restaurants, experiences, airlines, and cruises. In 2025, 42% of revenue came from the company's core Hotel and Other segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 46% of revenue in 2025, and TheFork, its dining brand, represented 12% of sales.

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

Share on Social Networks: